About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Pdss2kd
kidney disease
MGI:1856927
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Pdss2kd/Pdss2kd B6.CBACaH(CAST)-Pdss2kd MGI:3611218
hm2
Pdss2kd/Pdss2kd CBA/H-Pdss2kd MGI:3611217
hm3
Pdss2kd/Pdss2kd involves: C57BL/6 * CBA/H MGI:3805709


Genotype
MGI:3611218
hm1
Allelic
Composition
Pdss2kd/Pdss2kd
Genetic
Background
B6.CBACaH(CAST)-Pdss2kd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdss2kd mutation (1 available); any Pdss2 mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• tubulointerstitial nephritis with interstitial monouclear cell infiltration and tubular dilation
• the degree of interstitial nephritis is similar to homozygous mice in CBA/CaH background described previously

renal/urinary system
• tubulointerstitial nephritis with interstitial monouclear cell infiltration and tubular dilation
• the degree of interstitial nephritis is similar to homozygous mice in CBA/CaH background described previously

cellular
• the complete absence of mitochondrial matrix granules in the mutant tissue samples of kidney and to lesser extent in liver




Genotype
MGI:3611217
hm2
Allelic
Composition
Pdss2kd/Pdss2kd
Genetic
Background
CBA/H-Pdss2kd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdss2kd mutation (1 available); any Pdss2 mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
liver/biliary system

mortality/aging
• usually at 5 to 7 months

renal/urinary system
• urine became colorless as the animal aged
• increase in urinary protein at about 10 weeks of age
• 6 month old, but not 4 month old, mutants show tubulointerstitial nephritis and collapsing glomerulopathy
• kidney at 6 months of age shows tissue loss
• cysts were seen only in kidneys with very advanced lesions (J:5232)
• microcystic formations (J:197578)
• podocyte damage is seen at 6 months of age
• 6 month old mutants show collapsing glomerulopathy
• sclerotic in atrophied areas of the kidney (J:5232)
• at necropsy, kidneys appear contracted
• in the fully developed case in 4 to 6 months old mice, many of the tubules were atrophied in some places
• a small number of tubules were distended with colloid casts at 10 to 14 weeks of age
• in the fully developed case in 4 to 6 months old mice, many of the tubules were dilated and atrophied in some places
• a small number of tubules were distended with colloid casts at 10 to 14 weeks of age
• at necropsy
• at necropsy

behavior/neurological
• at 3 to 4 months of age
• mice become hunched at a few months of age

growth/size/body
• at the age of 4-6 months
• progressively worse until death
• cysts were seen only in kidneys with very advanced lesions (J:5232)
• microcystic formations (J:197578)

homeostasis/metabolism
• 1 month old mutants show CoQ9 levels that are 20% of controls in the brain, 28% in the kidney, 62% in the liver and 35% in the muscle
• 4 month old mutants show even further reduced levels of CoQ9, levels that are 16% of controls in the brain, 21% in the kidney, 25% in the muscle
• 6 month old mutants show CoQ9 levels that are 28% of controls in the brain, 14% in the kidney, 68% in the liver, and 20% in the muscle
• liver of 4 month old mutants has increased CoQ9; 157% of controls
• urine became colorless as the animal aged
• increase in urinary protein at about 10 weeks of age

cellular
• levels of mitochondrial DNA are decreased in the kidney (19%) at 4 months of age
• levels of mitochondrial DNA are decreased in the kidney (26%) and liver (71%) at 6 months of age
• levels of mitochondrial DNA are increased in the brain (128%), and liver (120%) at 4 months of age
• coenzyme Q (CoQ)-dependent complex I + III activity, normalized to citrate synthase activity, is reduced in the kidney at 4 and 6 months of age, and in the muscle at 6 months of age
• CoQ-dependent complex I + III activity, normalized to CS activity, is increased in the liver at 4 months of age, but not at 6 months
• CoQ-depended complex II + III activity, normalized to CS activity, is reduced in the kidney, brain, and liver, and slightly increased in the muscle of 1 month old mutants
• CoQ-depended complex II + III activity, normalized to CS activity, is reduced in the muscle at 6 months of age
• cytochrome c oxidase and citrate synthase activities are increased in the liver a 4 months of age
• citrate synthase activity is decreased in the kidney at 6 months of age
• ATP concentration and ATP/ADP ratio are decreased in the kidney, slightly decreased in muscle, and slightly increased in the brain and liver at 4 months of age
• ATP levels and ATP/ADP ratio are decreased in the kidney and brain but are increased in the liver and muscle at 6 months of age
• mutants show elevated reactive oxygen species (ROS) production in the kidney (at 1 and 4 months of age) and muscle (at 4 months of age, but not 6 months of age) following dihydroethidine injection compared to wild-type controls
• markers of oxidative stress are increased in sclerotic glomeruli, dilated tubuli, microcystic formations, and in some of the normal proximal and distal tubuli adjacent to affected areas at 6 months of age

immune system
• 6 month old, but not 4 month old, mutants show tubulointerstitial nephritis and collapsing glomerulopathy

muscle
• 4 and 6 month old mutants show variable muscle abnormalities, including central nuclei and fiber-type grouping and necrotic fibers

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
coenzyme Q10 deficiency disease DOID:0050730 OMIM:PS607426
J:197578




Genotype
MGI:3805709
hm3
Allelic
Composition
Pdss2kd/Pdss2kd
Genetic
Background
involves: C57BL/6 * CBA/H
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdss2kd mutation (1 available); any Pdss2 mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• microcysts
• focal injury to the parietal epithelium lining Bowman's capsule
• focal loss of primary processes of podocytes, and hyperplastic and hypertrophic podocytes
• diseased podocytes contain abnormal mitochondria
• extensive foot process effacement with marked condensation of the actin cytoskeleton
• folding and wrinkling of the glomerular basement membrane
• variable, age-dependent penetrance of collapsing glomerulopathy; segmental and global collapse of capillary loops with folding and wrinkling of the glomerular basement membrane
• diseased glomeruli show segmental and global sclerosis
• tubular atrophy

cellular
• impaired mitochondrial respiration
• significant decrease in complex I and complex II-dependent respiratory chain capacity in liver

growth/size/body
• microcysts





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory